Success Metrics

Clinical Success Rate
98.4%

Based on 60 completed trials

Completion Rate
98%(60/61)
Active Trials
2(3%)
Results Posted
35%(21 trials)
Terminated
1(1%)

Phase Distribution

Ph phase_1
4
6%
Ph phase_4
18
25%
Ph phase_3
17
24%
Ph phase_2
9
13%
Ph not_applicable
20
28%

Phase Distribution

4

Early Stage

9

Mid Stage

35

Late Stage

Phase Distribution68 total trials
Phase 1Safety & dosage
4(5.9%)
Phase 2Efficacy & side effects
9(13.2%)
Phase 3Large-scale testing
17(25.0%)
Phase 4Post-market surveillance
18(26.5%)
N/ANon-phased studies
20(29.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

98.4%

60 of 61 finished

Non-Completion Rate

1.6%

1 ended early

Currently Active

2

trials recruiting

Total Trials

72

all time

Status Distribution
Active(3)
Completed(60)
Terminated(1)
Other(8)

Detailed Status

Completed60
unknown8
Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
72
Active
2
Success Rate
98.4%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (5.9%)
Phase 29 (13.2%)
Phase 317 (25.0%)
Phase 418 (26.5%)
N/A20 (29.4%)

Trials by Status

completed6083%
recruiting23%
not_yet_recruiting11%
terminated11%
unknown811%

Recent Activity

Clinical Trials (72)

Showing 20 of 72 trialsScroll for more
NCT02216227Not Applicable

Checklist to Prevent MRSA Surgical Site Infections

Completed
NCT03489629Phase 2

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

Completed
NCT05110001Phase 3

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction

Completed
NCT03140254Phase 2

Evaluating Safety and Effectiveness of Octenidine Dihydrochloride

Completed
NCT00636480Phase 3

Preoperative Skin Preparation Evaluation

Completed
NCT00692484Phase 3

Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 Antiseptics

Completed
NCT06733506Phase 4

A Pilot Study to Evaluate Skin Swabbing With Chlorhexidine to Prevent Skin And Soft Tissue Infections Among People Who Inject Drugs

Completed
NCT06936475Not Applicable

Vaginal Cleansing With Chlorhexidine Versus Iodine for Prevention of Endometritis

Completed
NCT06464770Not Applicable

Optimizing Infection Prophylaxis Prior to Shoulder Surgery

Recruiting
NCT06691841Not Applicable

Effect of Chlorhexidine Gluconate in Oral Care of Patients With Endotracheal Intubation Based on 16sRNA Technology

Completed
NCT00516906Phase 2

Clinical Performance of a Chlorhexidine Antimicrobial Dressing

Completed
NCT06587880Phase 4

The Effect of Different Types of Mouthwash on Extraction Sockets' Healing

Not Yet Recruiting
NCT06126614Phase 3

Infection Prophylaxis in Total Joint Replacement

Recruiting
NCT06531720Not Applicable

Comparison of the Effects of Oral Ulceration Healing in Patients Wearing a Removable Denture

Completed
NCT06305546Not Applicable

Comparisons Of Different Antiplaque Agents On Gingivitis In Orthodontic Patients

Completed
NCT03331263Phase 1

Single Dose CHG Pharmacokinetic Study

Completed
NCT06144983Phase 4

Chlorhexidine Gel Versus Alvogyl Following Surgical Extraction of Impacted Mandibular Third Molar

Completed
NCT01105767Not Applicable

Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees

Completed
NCT02513784Not Applicable

Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome

Completed
NCT05059145Phase 2

A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
72